Net Cash Provided by (Used in) Operating Activities |
-3.5K |
USD |
+17.1% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
9K |
USD |
+80% |
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
708K |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-3.5K |
USD |
-173% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5.23K |
USD |
+48.1% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
99.3K |
USD |
+8.2% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
99.3K |
USD |
+8.2% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
25M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
25.1K |
USD |
0% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Interest Expense |
22K |
USD |
+8.62% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |